journal article·2026Open access

Enhanced stability and sustained delivery of structurally dense DNA nanostructures via a biodegradable hydrogel platform

Youngjin Choi, Yeonju Song, Bo Kyung Cho, Sang Jin Baek, Jin Myeong Wang, Su Hyun Seok, William M. Shih, Junsang Doh, Youngmee Jung, Ju Hee Ryu

Nanoscale Horizons· Volume 11· Issue 4

Abstract

DNA nanostructures offer programmable architectures with precise ligand arrangement, yet their in vivo utility is often limited by structural fragility and rapid systemic clearance. Here, we present a robust platform for the sustained delivery of structurally dense, multi-helical square block DNA nanostructures (SQBs) by encapsulating them within a biodegradable hydrogel composed of thiolated hyaluronic acid (HA) and gelatin. Distinct from DNA-based hydrogels where the DNA network serves as the structural matrix, this platform employs a decoupled architecture that entraps SQBs as discrete nanoparticles within a tunable polymeric matrix. This platform is engineered to maintain an Mg2+-rich microenvironment to preserve the structural integrity of SQB cargo, as evidenced by the intact morphology of nanostructures recovered from the matrix, while allowing independent control over degradation and release kinetics. In vitro, encapsulated SQBs retained their electrophoretic stability and exhibited release profiles governed by the hydrogel's crosslinking density and gelatin content. Importantly, SQB-hydrogel hybrids demonstrated sustained intracellular uptake in RAW 264.7 macrophages for up to 5 days, whereas free SQBs were rapidly internalized and cleared within 3 days. In vivo subcutaneous administration further confirmed that the hybrid system maintained detectable fluorescence for 10 days, significantly outperforming free SQBs, which were cleared within 24 hours. These findings establish a versatile hydrogel framework that effectively serves as a sustained depot for complex DNA nanostructures, offering a generalizable strategy for their localized and long-term deployment in therapeutic applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea

Biomaterials Research Center, Biomedical Research Institute KIST, Seoul, Republic of Korea

Department of Materials Science and Engineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, Republic of Korea

KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea

Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA

Research Institute of Advanced Materials, Seoul National University, Seoul, Korea

Institute of Engineering Research: SOFT Foundry Institute, Bio-MAX Institute, Seoul National University, Seoul, 08826, Republic of Korea

School of Electrical and Electronic Engineering, YU-KIST Institute, Yonsei University, Seoul, Republic of Korea

Funding

Ministry of Science and ICT, South Korea

References (34)

Show source-provided references
1. Li · Nano Lett. · 2024 · 24 · 1133510.1021/acs.nanolett.4c03297 ↗
2. Zhan · Chem. Rev. · 2023 · 123 · 397610.1021/acs.chemrev.3c00028 ↗
3. Douglas · Nature · 2009 · 459 · 41410.1038/nature08016 ↗
4. Ke · J. Am. Chem. Soc. · 2009 · 131 · 1590310.1021/ja906381y ↗
5. Zeng · Nat. Nanotechnol. · 2024 · 19 · 105510.1038/s41565-024-01615-3 ↗
6. Rosier · Nat. Catal. · 2020 · 3 · 29510.1038/s41929-019-0403-7 ↗
7. Veneziano · Nat. Nanotechnol. · 2020 · 15 · 71610.1038/s41565-020-0719-0 ↗
8. Fang · ACS Nano · 2021 · 15 · 344110.1021/acsnano.0c10632 ↗
9. Yin · Nat. Mater. · 2024 · 23 · 85410.1038/s41563-024-01826-y ↗
10. Spratt · Nat. Nanotechnol. · 2024 · 19 · 23710.1038/s41565-023-01507-y ↗
11. Chen · Small Methods · 2025 · 9 · 240199310.1002/smtd.202401993 ↗
12. Mei · Adv. Funct. Mater. · 2022 · 32 · 211254410.1002/adfm.202112544 ↗
13. Li · MedComm – Biomater. Appl. · 2023 · 2 · e37
14. Li · Nat. Biotechnol. · 2018 · 36 · 25810.1038/nbt.4071 ↗
15. Xu · Front. Chem. · 2020 · 8 · 75110.3389/fchem.2020.00751 ↗
16. Jiang · Nat. Biomed. Eng. · 2018 · 2 · 86510.1038/s41551-018-0317-8 ↗
17. Wamhoff · ACS Appl. Bio. Mater. · 2023 · 6 · 196010.1021/acsabm.3c00155 ↗
18. Messaoudi · Adv. Therap. · 2019 · 2 · 190014410.1002/adtp.201900144 ↗
19. Han · J. Controlled Release · 2022 · 343 · 37910.1016/j.jconrel.2022.01.049 ↗
20. Ramakrishnan · Comput. Struct. Biotechnol. · 2018 · 16 · 34210.1016/j.csbj.2018.09.002 ↗
21. Liu · Nano Lett. · 2024 · 24 · 841010.1021/acs.nanolett.4c02104 ↗
22. Ponnuswamy · Nat. Commun. · 2017 · 8 · 1565410.1038/ncomms15654 ↗
23. Nasiri · Int. J. Biol. Macromol. · 2024 · 260 · 12949510.1016/j.ijbiomac.2024.129495 ↗
24. Lachance-Brais · Adv. Sci. · 2023 · 10 · e220571310.1002/advs.202205713 ↗
25. Tang · Adv. Mater. Technol. · 2022 · 7 · 220006610.1002/admt.202200066 ↗
26. Shahbazi · Adv. Therap. · 2018 · 1 · 180004210.1002/adtp.201800042 ↗
27. Lei · J. Controlled. Release · 2011 · 153 · 25510.1016/j.jconrel.2011.01.028 ↗
28. Yamaguchi · DNA · 2022 · 2 · 30210.3390/dna2040021 ↗
29. Torres-de la Roche · J. Clin. Med. · 2022 · 11 · 93110.3390/jcm11040931 ↗
30. Young · Small Methods · 2025 · 9 · 240137610.1002/smtd.202401376 ↗
31. Zustiak · Biomacromolecules · 2010 · 11 · 134810.1021/bm100137q ↗
32. Axpe · Macromolecules · 2019 · 52 · 688910.1021/acs.macromol.9b00753 ↗
33. Ramakrishnan · Small · 2017 · 13 · 170210010.1002/smll.201702100 ↗
34. Linko · Small · 2023 · 19 · 230193510.1002/smll.202301935 ↗